Nova Leah
Dundalk
About Nova Leah
Nova Leah believe in excellence through knowledge development, sharing and collaboration to enhance the security assurance of medical devices. Nova Leah's product, SelectEvidence, is an intelligent cybersecurity risk management compliance solution aimed at medical device manufacturers and healthcare providers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.3M
- Last round: Series Unknown (Dec 2021)
- Website: novaleah.com
- Phone: 353 42 9343033
Industries & Categories
Compliance, Cyber Security, Enterprise Software, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/nova-leah-73140 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.